Advances in Diagnosis and Management of Urological Diseases

Dear Colleagues,

The management of critically ill patients is of utmost importance. Urological diseases contribute to a significant decline in life quality, especially when the disease is diagnosed at a late stage, providing limited options for health improvement. Advanced stages of the disease progression are often critical, so prompt diagnosis is crucial for preventing such outcomes. The characterization of novel and more accurate clinical markers will allow on-time capture of disease onset, avoiding urinary track system deterioration. Proteins and other biomolecules provide a great opportunity to monitor the disease on a molecular level. Changes in these molecular features are pivotal for the expression of molecular pathways and disease pathogenesis. High-throughput technology for biomarker discovery, validation, and drug development is required for improved risk stratification, better and more cost-effective medical care, and advanced personalized medicine. In line with those strategies, this Special Issue of Diagnostics will be devoted to the latest development of up-to-date studies and findings in the area of urological disease that could be translated into clinical practice for prospective patient management.

We invite scientists to submit articles presenting new achievements in urological diseases. We very much look forward to your submission.

Dr. Martin Pejchinovski
Dr. Jochen Metzger
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• proteomics
• biomarkers
• diagnosis
• prediction
• treatment
• clinical application
• technical advances